For which of these patients would you give the 23-valent pneumoccocal vaccine?
Which of the following should get the 23-valent pneumoccocal (Pneumovax) vaccine per the Advisory Committee on Immunization Practices (ACIP) guidelines?
RSV Vaccines Found Safe and Effective Across High-Risk Groups in Cochrane Review
Vaccines for respiratory syncytial virus were found both safe and effective across 100,000 participants and, critically, for older adults and for infants.
Countering Vaccine Misinformation in Clinical Practice with Amesh Adalja, MD: Primary Viewpoints Podcast
Infectious disease expert shares strategies for PCPs to counter vaccine myths, navigate policy changes, and build patient trust.
High-Dose Flu Vaccine Cuts Myocarditis, Pericarditis Risk in Older Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
Weekly Dose: A Roundup of Top Stories for Primary Care Physicians
PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.
Physicians Attending Day 1 of ACIP Meeting Said They Need to be Heard
Discussions on day 1 focused on the difference between the MMR and MMR+V vaccines, with clinicians calling for inclusion of real-world experience in any ACIP decision.
The ACIP Meets on September 18 as Vaccine Policy Hangs in the Balance
Regardless of decisions made during the ACIP meeting, health insurance plans will continue to cover shots recommended by ACIP as of Sept 1.